anti-DD-0110 monoclonal antibody (CFD)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-DD-0110 monoclonal antibody (CFD)
Drug Alias Nameanti-B7H4 antibodies (CFD)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionV-set domain-containing T-cell activation inhibitor 1 modulators
TargetsV-set domain-containing T-cell activation inhibitor 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCFD Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCFD Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A